Control of breast tumor cell growth using a targeted cysteine protease inhibitor

Cancer Research

Volumn 58, Issue 5, 1998, Pages 904-909

  Xing, Ruye ^a   Wu, Fei ^a   Mason, Robert W ^a  

^a NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; CYSTEINE PROTEINASE INHIBITOR; MONOCLONAL ANTIBODY;

ARTICLE; BREAST TUMOR; CANCER INHIBITION; CELL STRAIN MCF 7; HUMAN; HUMAN CELL; INTERNALIZATION; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CELL DIVISION; CYSTEINE PROTEINASE INHIBITORS; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; RECEPTOR, ERBB-2; TUMOR CELLS, CULTURED;

EID: 0032032628     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Lloyd, J. B., and Mason, R. W. (eds.), Subcellular Biochemistry, Vol. 27. Biology of the Lysosome. New York: Plenum Press, 1996.
2. Sloane, B. F., Dunn, J. R., and Honn, K. V. Lysosomal cathepsin B: correlation with metastatic potential. Science (Washington DC), 212: 1151-1153, 1981.
3. Sloane, B. F., Rozhin, J., Johnson, K., Taylor, H., Crissman, J. D., and Honn, K. V. Cathepsin B: association with plasma membrane in metastatic tumors. Proc. Natl. Acad. Sci. USA, 83: 2483-2487, 1986.
4. Denhardt, D. T., Greenberg, A. H., Egan, S. E., Hamilton, R. T., and Wright, J. A. Cysteine protease cathepsin L expression correlates closely with the metastatic potential of H-ras-transformed murine fibroblasts. Oncogene, 2: 55-59, 1987.
5. Pietras, R. J., Szego, C. M., Roberts, J. A., and Seeler, B. J. Lysosomal cathepsin B-like activity: mobilization in prereplicative and neoplastic epithelial cells. J. Histochem. Cytochem., 29: 440-450, 1981.
6. Shoji-Kasai, Y., Senshu, M., Iwashita, S., and Imahori, K. Thiol protease-specific inhibitor E-64 arrests human epidermoid carcinoma A431 cells at mitotic metaphase. Proc. Natl. Acad. Sci. USA, 85: 146-150, 1988.
7. Kobayashi, H., Moniwa, N., Sugimura, M., Shinohara, H., Ohi, H., and Terao, T. Effects of membrane-associated cathepsin B on the activation of receptor-bound prourokinase and subsequent invasion of reconstituted basement membranes. Biochim. Biophys. Acta, 1178: 55-62, 1993.
8. Young, P. R., and Spevacek, S. M. Substratum acidification and protease activation by murine B16F10 melanoma cultures. Biochim. Biophys. Acta, 1182: 69-74, 1993.
9. Crawford, C., Mason, R. W., Wikstrom, P., and Shaw, E. The design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteases calpain II, cathepsin L and cathepsin B. Biochem. J., 253: 751-758, 1988.
10. 2-macroglobulin: conclusive evidence for endopeptidase activities of cathepsins B and H. Arch. Biochem. Biophys., 273: 367-374, 1989.
11. 125I]iodotysylalanydiazomethane as a probe for active cysteine proteases in human tissue. Biochem. J., 263: 945-949, 1989.
12. Mason, R. W., Wilcox, D., Wikstrom, P., and Shaw, E. N. The identification of active forms of cysteine proteases in Kirsten-virus-transformed mouse fibroblasts by use of a specific radiolabelled inhibitor. Biochem. J., 257: 125-129, 1989.
13. Wilcox, D., and Mason, R. W. Inhibition of cysteine proteases in lysosomes and whole cells. Biochem. J., 285: 495-502, 1992.
14. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., and McGuire, L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (Washington DC), 235: 177-182, 1987.
15. Slamon, D. J., Godolphin, W., Jones, L., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., and Press, M. F. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science (Washington DC), 244: 707-712, 1989.
16. Lofts, F. J., and Gullick, W. J. c-erbB2 amplification and overexpression in human tumors. In: R. B. Dickson and M. E. Lippman (eds.), Genes, Oncogenes, and Hormones: Advances in Cellular and Molecular Biology of Breast Tumor, pp. 161-179. Boston: Kluwer Academic Publishers, 1991.
17. Press, M. F., Cordon-Cardo, C., and Slamon, D. J. Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. Oncogene, 5: 953-962, 1990.
18. HER2 antibody for human cancer therapy. Proc. Natl. Acad. Sci. USA, 89: 4285-4289, 1992.
19. Dougall, W. C., and Greene, M. I. Biological studies and potential therapeutic applications of monoclonal antibodies and small molecules reactive with the neu/c-erbB-2 protein. Cell Biophys., 24-25: 209-218, 1994.
20. HER2 monoclonal antibodies: biological properties and potential for immunotherapy. In: R. B. Dickson and M. E. Lippman (eds.), Genes, Oncogenes, and Hormones: Advances in Cellular and Molecular Biology of Breast Cancer, pp. 193-211. Boston: Kluwer Academic Publishers, 1991.
21. HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. J. Clin. Oncol., 14: 737-744, 1996.
22. Holzman, D. HER2/neu gene bumped into the limelight. J. Natl. Cancer Inst., 88: 147-148, 1996.
23. c-erbB-2 signaling enhances cisplatin-induced cytotoxicity in human breast carcinoma cells: association between an oncogenic receptor tyrosine kinase and drug-induced DNA repair. Cancer Res., 54: 3758-3765, 1994.
24. Pietras, R. J., Fendley, B. M., Chazin, V. R., Pegram, M. D., Howell, S. B., and Slamon, D. J. Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells. Oncogene, 9: 1829-1838, 1994.
25. Carlsson, J., Drevin, H., and Axen, R. Protein thiolation and reversible protein-protein conjugation. Biochem. J., 173: 723-737, 1978.
26. Cumber, A. J., Forrester, J. A., Foxwell, B. M. J., Ross, W. C. J., and Thorpe, P. E. Preparation of antibody-toxin conjugates. Methods Enzymol., 112: 207-225, 1985.
27. Garfin, D. E. One-dimensional gel electrophoresis. Methods Enzymol., 182: 425-441, 1990.
28. Lan, T. T., Kokalj-Kunovar, M., Strukelj, B., Pungercar, J., Barlic Maganja, D., Drobnic-Kosorok, M., Kastelic, L., Babnik, J., and Turk, V. Stefins, lysosomal cathepsins B, L, and D in human breast carcinoma. Int. J. Cancer, 50: 1-9, 1991.
29. Jean, D., Hermann, J., Rodrigues-Lima, F., Barel, M., Balbo, M., and Frade, R. Identification on melanoma cells of p39, a cysteine protease that cleaves the third component of complement: amino acid sequence identities with procathepsin L. Biochem. J., 312: 961-969, 1995.
30. Jean, D., Bar-Eli, M., Huang, S., Xie, K., Rodrigues-Lima, F., Hermann, J., and Frade, R. A cysteine protease, which cleaves human C3, the third component of complement, is involved in tumorigenicity and metastasis of human melanoma. Cancer Res., 56: 254-258, 1996.
31. Thompson, E. W., Paik, S., Brunner, N., Sommers, C. L., Zugmaier, G., Clarke, R., Shima, T. B., Torri, J., Donahue, S., Lippman, M. E., Martin, G. R., and Dickson, R. B. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J. Cell. Physiol., 150: 534-544, 1992.
32. Gal, S., Willingham, M. C., and Gottesman, M. M. Processing and lysosomal location of a glycoprotein whose secretion is transformation stimulated. J. Cell Biol., 100: 535-544, 1985.
33. Li, R., Chen, X., Gong, B., Selzer, P. M., Li, Z., Davidson, E., Kurzban, G., Miller, R. E., Nuzum, E. O., McKerrow, J. H., Fletterick, R. J., Gillmor, S. A., Craik, C. S., Kuntz, I. D., Cohen, F. E., and Kenyon, G. L. Structure-based design of parasitic protease inhibitors. Bioorg. Med. Chem. Lett., 4: 1421-1427, 1996.
34. Beckman, D. A., Brent, R. L., and Lloyd, J. B. Pinocytosis in the rat visceral yolk sac: potential role in amino acid nutrition during the fetal period. Placenta, 15: 171-176, 1994.
35. 2). Teratology, 50: 214-228, 1994.